13FPulse
GM

GMED GLOBUS MEDICAL INC - A

2026Q2 · CUSIP 379577208 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
586
Institutions that reported holding it to the SEC
Net decrease in holders
16
Last quarter 602 → now 586
How unusual is that
Bottom 20%
Stronger than only 9% of US stocks
What the filings say, in one paragraph

586 funds held GMED at the end of 2026Q2, down 16 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $3.1B(YoY +19.7%), the P/E is 20.7x, return on equity is 11.2%. GMED has had 23 buying rushes in its history, and the price moved +9.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=118 2013Q4: holders=134 2014Q1: holders=157 2014Q2: holders=172 2014Q3: holders=165 2014Q4: holders=184 2015Q1: holders=179 2015Q2: holders=179 2015Q3: holders=180 2015Q4: holders=191 2016Q1: holders=203 2016Q2: holders=208 2016Q3: holders=196 2016Q4: holders=208 2017Q1: holders=244 2017Q2: holders=242 2017Q3: holders=251 2017Q4: holders=262 2018Q1: holders=279 2018Q2: holders=291 2018Q3: holders=310 2018Q4: holders=301 2019Q1: holders=270 2019Q2: holders=259 2019Q3: holders=267 2019Q4: holders=307 2020Q1: holders=273 2020Q2: holders=319 2020Q3: holders=343 2020Q4: holders=348 2021Q1: holders=342 2021Q2: holders=354 2021Q3: holders=387 2021Q4: holders=372 2022Q1: holders=375 2022Q2: holders=360 2022Q3: holders=368 2022Q4: holders=390 2023Q1: holders=391 2023Q2: holders=381 2023Q3: holders=431 2023Q4: holders=407 2024Q1: holders=436 2024Q2: holders=450 2024Q3: holders=449 2024Q4: holders=503 2025Q1: holders=517 2025Q2: holders=484 2025Q3: holders=487 2025Q4: holders=563 2026Q1: holders=602 2026Q2: holders=586 -76 -38 +0 +38 +76 106370633 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 23 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 10%
2025Q4 Top 10% -7.6%
2025Q1 Top 20% +0.2% +37.0%
2024Q4 Top 10% -27.0% -28.2%
2024Q2 Top 20% +16.1% +20.4%
2024Q1 Top 10% +8.7% +25.9%
2023Q3 Top 5% +17.2% +43.4%
2022Q4 Top 20% -6.2% -9.1%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
222
Change in large funds
+5
Total value they hold
$9.4B
Funds buying for the first time
83
Funds that sold out entirely
99
Price change that quarter
+2.2%
Funds holding puts (bearish)
6
Funds holding calls (bullish)
7

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
20.7
EPS (TTM)
$3.89
EPS YoY
+49.6%
Revenue (TTM)
$3.1B
Revenue YoY
+19.7%
Net margin
17.0%
ROE
11.2%
Debt ratio
13.1%
FCF (TTM)
$756M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 0.45 2021-12-31: EPS 0.15 2022-03-31: EPS 0.37 2022-06-30: EPS 0.53 2022-09-30: EPS 0.47 2022-12-31: EPS 0.48 2023-03-31: EPS 0.48 2023-06-30: EPS 0.57 2023-09-30: EPS 0.01 2023-12-31: EPS 0.01 2024-03-31: EPS -0.05 2024-06-30: EPS 0.23 2024-09-30: EPS 0.38 2024-12-31: EPS 0.19 2025-03-31: EPS 0.54 2025-06-30: EPS 1.49 2025-09-30: EPS 0.88 2025-12-31: EPS 1.01 2026-03-31: EPS 0.90 2026-06-30: EPS 1.10 0M 413M 826M $M -0.06 0.79 1.64 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 33 16 191 367 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
0K107M214M 20162017201820192020202120222023202420252026
Latest quarter $163M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.